Susan L. Coultas

Dr. Coultas has served as the Chief Clinical Officer since June 2022. She brings 35 years of experience in clinical development in the biopharmaceutical industry. Most recently, Dr. Coultas served as Senior Vice President of Clinical Development at Kala Pharmaceuticals, where she was responsible for the planning and execution of its clinical programs, resulting in two new drug application filings and product approvals. Dr. Coultas has worked with multiple ophthalmic companies, both internally and as a consultant, including Alcon Laboratories, Inc., CibaVision Ophthalmics, Sucampo Pharmaceuticals, and Bausch+Lomb, Inc. Earlier in her career, as the owner of InfoQuest Clinical Network, Inc., Dr. Coultas successfully identified, developed, and led a large network of clinical research professionals that managed numerous clinical trials in multiple systemic and ophthalmic therapeutic areas. Dr. Coultas earned a Ph.D. in Public Health, and Epidemiology, from Walden University, an M.S. in Biology from the University of North Texas, and a B.S. in Biology from Texas Wesleyan University.